We believe this site might serve you best:

United States

English Continue

This country code will remain if no action is taken to change it.

Don't see your country?
Promega Corporation

CDK6/CyclinD3 Kinase Enzyme System

See All Kinase Enzyme Systems
Recombinant full-length human CDK6 and CyclinD3 were co-expressed by baculovirus in Sf9 insect cells using an N-terminal His tag on both proteins. CDK6 is a member of the cyclin-dependent family of protein kinases that are important regulators of cell cycle progression. CDK6 activity is regulated by the D-type cyclins and members of the INK4 family of CDK inhibitors (1). The CDK6 kinase activity is detected in mid-G1 phase of the cell cycle and is responsible for the phosphorylation and regulation of the activity of tumor suppressor protein Rb. Although CDK6 and CDK4 can both phosp...

Expand to Read More »

  • Print
  • Email
  • Prices valid for US customers only
Product Size Conc. Catalog # *List Price Order QTY Add to Cart
CDK6/CyclinD3 Kinase Enzyme System
Close Window

CDK6/CyclinD3 Kinase Enzyme System  Components

10μg
- V4510 $ 406.00 Add to cart

CDK6/CyclinD3 Kinase Enzyme System

Close Window

CDK6/CyclinD3 Kinase Enzyme System

 Components

1mg
- V6282 $ 5,990.00 Add to cart
ADP-Glo™ Kinase Assay + CDK6/CyclinD3 Kinase Enzyme System
Close Window

ADP-Glo™ Kinase Assay + CDK6/CyclinD3 Kinase Enzyme System  Components

  • CDK6/CyclinD3 Kinase Enzyme System

    V45101 x 10μg
  • ADP-Glo™ Kinase Assay

    V91011 x 1,000 assays
1 each
- V4511 $ 808.00 Add to cart


You Also May Be Interested In

Storage Conditions

Upon receipt, centrifuge the kinase and dispense it into smaller quantities. Store the kinase at –70°C and the rest of the components at –20°C.

For product intended use please see Patents & Disclaimers tab.

Use Restrictions

V4510, V6282, V4511 For Research Use Only. Not for Use in Diagnostic Procedures.

Patents - Disclaimers

V4511 U.S. Pat. Nos. 7,083,911, 7,452,663 and 7,732,128 and other patents.

V4511 U.S. Pat. No. 7,700,310 and other patents and patents pending.

V4511 U.S. Pat. Nos. 7,741,067, 8,361,739, 8,603,767 and other patents and patents pending.

V4511 U.S. Pat. Nos. 6,602,677, 7,241,584 and 8,030,017 and other patents and patents pending.

V4511 U.S. Pat. No. 8,183,007 and other patents and patents pending.

V4511 Licensed from Lonza Nottingham Ltd. under U.S. Pat. Nos. 6,599,711 and 6,911,319 and other pending and issued patents.

V4511 The method of recombinant expression of Coleoptera luciferase is covered by U.S. Pat. Nos. 5,583,024, 5,674,713 and 5,700,673.

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.

Scientists at Your Service

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.